Now Reading
Biogen Recognized As One of America's Most JUST Companies
Biogen Recognized As One of America's Most JUST Companies
Published 01-13-22
Submitted by Biogen
JUST Capital and CNBC have recognized Biogen's dedication to addressing science for the betterment of humanity by ranking us in the top 50 the JUST100 list of America's Most JUST companies.
Biogen was recognized as #36 of 954 companies, reflecting our performance and sustained commitment to ESG.
We work to have an impact beyond our therapies as we strive to improve patient health outcomes, solve social and environmental challenges, cultivate a workplace that enables our employees to thrive, support local communities, and inspire future generations of scientists.
Learn more about Biogen's commitments
Biogen
Biogen
Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease. Biogen is advancing a pipeline of potential novel therapies across neurology, neuropsychiatry, specialized immunology and rare diseases and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.
More from Biogen
